Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02742974Terminated
Randomised, open-label trial (2 arms), sponsored by CAMC Health System. Primary endpoint: Incidence of Post-operative Complications up to 6 months. Started Oct 2015; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02742974.